Prospective, non-comparative, non-interventional, observational study to collect and analyse real life environment data on advanced prostate cancer patients receiving combination treatment of medical or surgical castration and bicalutamide according to routine medical practice in Croatia. The main aim is to evaluate change of PSA level and prescribing practices based on prostate cancer stage.
Study Type
OBSERVATIONAL
Enrollment
340
Research Site
Čakovec, Croatia
Research Site
Dubrovnik, Croatia
Research Site
Karlovac, Croatia
To evaluate change in PSA level following 4-9 months of bicalutamide therapy
Time frame: PSA - 2 measures (at the time of bicalutamdie introduction and 4-9 m following bicalutamide)
bicalutamide prescribing practice based on prostate cancer stage
Time frame: 1 measure (at the time of bicalutamde th introduction)
to evaluate PSA level after 4-12 weeks of bicalutamide therapy
Time frame: PSA - 1 measures (1-3 m following bicalutamide)
to asses time to disease progression based on PSA values
Time frame: PSA - 3 measures (at the time of bicalutamdie introduction, 1-3 m and 4-9 m following bicalutamide)
to evaluate percentage of patients with disease progression
Time frame: 2 measures at 1st and 2nd visit
to evaluate withdrawals due to adverse events
Time frame: 2 measures, at 1st and 2nd visit
to evaluate withdrawals due to Croatian Institute for Health Insurance guidelines for bicalutamide prescription
Time frame: 2 measures, at 1st and 2nd visit
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Research Site
Pula, Croatia
Research Site
Rijeka, Croatia
Research Site
Sisak, Croatia
Research Site
Slavonski Brod, Croatia
Research Site
Split, Croatia
Research Site
Šibenik, Croatia
Research Site
Vinkovci, Croatia
...and 5 more locations